PortfoliosLab logoPortfoliosLab logo
AEHR vs. NVDA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AEHR vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aehr Test Systems (AEHR) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AEHR achieves a 373.40% return, which is significantly higher than NVDA's 12.01% return. Over the past 10 years, AEHR has underperformed NVDA with an annualized return of 49.80%, while NVDA has yielded a comparatively higher 68.47% annualized return.


AEHR

1D
-2.92%
1M
-1.70%
YTD
373.40%
6M
300.42%
1Y
742.86%
3Y*
30.98%
5Y*
104.84%
10Y*
49.80%

NVDA

1D
1.73%
1M
-2.94%
YTD
12.01%
6M
12.58%
1Y
47.43%
3Y*
75.35%
5Y*
64.54%
10Y*
68.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AEHR vs. NVDA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AEHR
Aehr Test Systems
373.40%21.41%-37.32%31.99%-16.87%855.73%26.50%41.84%-47.97%12.45%
NVDA
NVIDIA Corporation
12.01%38.92%171.25%239.02%-50.26%125.48%122.30%76.94%-30.82%81.99%

Correlation

The correlation between AEHR and NVDA is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.33

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (5Y)
Calculated over the trailing 5-year period

0.43

Correlation (10Y)
Calculated over the trailing 10-year period

0.32

Correlation (All Time)
Calculated using the full available price history since Jan 25, 1999

0.19

The correlation between AEHR and NVDA shifts across timeframes, from 0.19 (all time) to 0.43 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AEHR:

$2.93B

NVDA:

$5.09T

EPS

AEHR:

-$0.38

NVDA:

$6.53

PS Ratio

AEHR:

63.83

NVDA:

20.13

PB Ratio

AEHR:

21.14

NVDA:

26.03

Total Revenue (TTM)

AEHR:

$45.26M

NVDA:

$253.49B

Gross Profit (TTM)

AEHR:

$13.90M

NVDA:

$187.95B

EBITDA (TTM)

AEHR:

-$13.56M

NVDA:

$192.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AEHR vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AEHR
AEHR Risk / Return Rank: 9797
Overall Rank
AEHR Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
AEHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
AEHR Omega Ratio Rank: 9494
Omega Ratio Rank
AEHR Calmar Ratio Rank: 9999
Calmar Ratio Rank
AEHR Martin Ratio Rank: 9999
Martin Ratio Rank

NVDA
NVDA Risk / Return Rank: 7777
Overall Rank
NVDA Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
NVDA Sortino Ratio Rank: 7575
Sortino Ratio Rank
NVDA Omega Ratio Rank: 7373
Omega Ratio Rank
NVDA Calmar Ratio Rank: 7979
Calmar Ratio Rank
NVDA Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AEHR vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aehr Test Systems (AEHR) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AEHRNVDADifference
Sharpe ratioReturn per unit of total volatility

+4.96

Sortino ratioReturn per unit of downside risk

+2.36

Omega ratioGain probability vs. loss probability

1.50

1.24

+0.27

Calmar ratioReturn relative to maximum drawdown

17.73

2.36

+15.37

Martin ratioReturn relative to average drawdown

40.02

5.73

+34.29

AEHR vs. NVDA - Sharpe Ratio Comparison

The current AEHR Sharpe Ratio is 6.34, which is higher than the NVDA Sharpe Ratio of 1.37. The chart below compares the historical Sharpe Ratios of AEHR and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AEHRNVDADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

6.34

1.37

+4.96

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.96

1.25

-0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.53

1.38

-0.85

Sharpe Ratio (All Time)

Calculated using the full available price history

0.08

0.63

-0.55

Drawdowns

AEHR vs. NVDA - Drawdown Comparison

The maximum AEHR drawdown since its inception was -97.98%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for AEHR and NVDA.


Loading charts...

Drawdown Indicators


AEHRNVDADifference

Max Drawdown

Largest peak-to-trough decline

-97.98%

-89.72%

-8.26%

Max Drawdown (1Y)

Largest decline over 1 year

-42.31%

-20.21%

-22.10%

Max Drawdown (3Y)

Largest decline over 3 years

-87.37%

-36.88%

-50.49%

Max Drawdown (5Y)

Largest decline over 5 years

-87.37%

-66.34%

-21.03%

Max Drawdown (10Y)

Largest decline over 10 years

-87.37%

-66.34%

-21.03%

Current Drawdown

Current decline from peak

-18.01%

-11.39%

-6.62%

Average Drawdown

Average peak-to-trough decline

-79.64%

-36.20%

-43.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.70%

8.30%

+10.40%

Volatility

AEHR vs. NVDA - Volatility Comparison

Aehr Test Systems (AEHR) has a higher volatility of 41.80% compared to NVIDIA Corporation (NVDA) at 13.14%. This indicates that AEHR's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AEHRNVDADifference

Volatility (1M)

Calculated over the trailing 1-month period

41.80%

13.14%

+28.66%

Volatility (6M)

Calculated over the trailing 6-month period

87.81%

26.37%

+61.44%

Volatility (1Y)

Calculated over the trailing 1-year period

118.61%

34.81%

+83.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

109.78%

51.75%

+58.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.87%

49.85%

+44.02%

Dividends

AEHR vs. NVDA - Dividend Comparison

AEHR has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.14%.


PositionTTM20252024202320222021202020192018201720162015
AEHR
Aehr Test Systems
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.14%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%

Financials

AEHR vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Aehr Test Systems and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
10.31M
81.62B
(AEHR) Total Revenue
(NVDA) Total Revenue
Values in USD except per share items

AEHR vs. NVDA - Profitability Comparison

The chart below illustrates the profitability comparison between Aehr Test Systems and NVIDIA Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
32.7%
74.9%
Portfolio components
AEHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aehr Test Systems reported a gross profit of 3.37M and revenue of 10.31M. Therefore, the gross margin over that period was 32.7%.

NVDA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.

AEHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aehr Test Systems reported an operating income of -4.23M and revenue of 10.31M, resulting in an operating margin of -41.0%.

NVDA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.

AEHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aehr Test Systems reported a net income of -3.20M and revenue of 10.31M, resulting in a net margin of -31.1%.

NVDA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.


Frequently Asked Questions


AEHR and NVDA have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AEHR has higher volatility (41.80%) compared to NVDA (13.14%). In terms of maximum drawdown, AEHR dropped -97.98% vs NVDA's -89.72%.

AEHR currently has the higher Sharpe Ratio (6.34 vs 1.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AEHR and NVDA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer